Is nuclear power a necessary part of the energy transition away from fossil fuels? As the debate rages on, new technologies and smaller reactors may be shifting the balance.
A rift in thinking about who should control powerful new technologies sent the brothers on diverging paths. For one, the story ended with a mission to bring science to the public.
Materials scientists are cooking up environmentally friendly polymers from natural sources like silk, plant fibers and whole algae. Economics and acceptance remain hurdles.
With the first medical therapy approved and systems like CRISPR-Cas showing up in complex cells, there’s a lot going on in the genome editing field. Here’s our primer.
Polygenic risk scores — a patient’s chance, based on tiny DNA variants, of developing cardiovascular disease, breast cancer and more — are coming to clinics. But there are kinks to iron out and accuracy remains an issue.
OPINION: A massive bias in medical studies toward men of European origin means that genetic variants in understudied populations don’t get the focus they deserve
An international treaty aims to bring the shipping industry to net-zero emissions by around 2050. Can novel fuels, wind power and coordination on a global scale get it there?
As wind power grows around the world, so does the threat the turbines pose to wildlife. From simple fixes to high-tech solutions, new approaches can help.
Scientists have been chasing the dream of harnessing the reactions that power the Sun since the dawn of the atomic era. Interest, and investment, in the carbon-free energy source is heating up.
Embedded in a cell phone or in accessories such as rings, bracelets or watches, the novel tools aim to make it easier to manage hypertension. But they must still pass several tests before hitting the clinic.
Deploying a motley crew of robots that can roll, walk and fly is a smart strategy for search-and-rescue operations — and so is trusting the machines to make decisions on the ground
The pandemic put the technology, long in development, to the test. Here’s a look at the status of its application to cancer and when it might reach patients.
